NCT02788604 Improving Quality of Life of Children With Cancer Through Psychosocial Screening Status COMPLETED Phase NA
NCT02787330 Assessing the Efficacy of a Psychosocial Intervention Program for Siblings of Children With Cancer Status COMPLETED Phase NA
NCT02785341 Adaptated Physical Activity During Chemotherapy: Evaluation of the Psychological, Physiological and Biological Impact Status TERMINATED Phase NA
NCT02782871 RCT: Compare - Pneupac VR1 to Manual Ventilation in Intubated Patients Status WITHDRAWN Phase NA
NCT02780375 Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects Status COMPLETED Phase N/A
NCT02779725 SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention Status COMPLETED Phase NA
NCT02777788 Curative Study of Chinese Traditional Medicine to Treat Lung Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT02777697 Cancer Chronic Pain Predicted by Emotional and Cognitive Status Status COMPLETED Phase N/A
NCT02777060 Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures Status UNKNOWN Phase NA
NCT02774369 Improving Sleep Among Cancer Patients: Comparison Between Physical Activity and Self-administered Cognitive-behavioral Therapy (CBT) Status COMPLETED Phase NA
NCT02773329 Using Game-based Exercise to Improve Balance in Cancer Patients Status COMPLETED Phase PHASE2
NCT02771028 Emotional Freedom Techniques to Reduce Patient Reported Cognitive Complaints in Cancer Survivors Status COMPLETED Phase NA
NCT02770326 Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection Status COMPLETED Phase NA
NCT02768428 Effectiveness of Knowledge by Video and Handbook of Liver Cancer Patients With First Trans-arterial Chemoembolization Status UNKNOWN Phase NA
NCT02765451 Study Evaluating Intervention in the Development of Clinical Research in Non-Academic Health Institution (ERNU) Status COMPLETED Phase NA
NCT02761824 Activity Based Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer Status COMPLETED Phase NA
NCT02761694 Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001) Status TERMINATED Phase PHASE1